Letermovir breakthroughs during the French Named Patient Programme: interest of monitoring blood concentration in clinical practice.

Alain, S.; Feghoul, L.; Girault, S.; Lepiller, Q.; Frobert, É.; Michonneau, D.; Berceanu, A.; Ducastelle-Leprêtre, S.; Tilloy, V.; Guérin, E.; Le Goff, J.; Peytavin, G.; Hantz, S.

doi:10.1093/jac/dkaa135

Public

Letermovir breakthroughs during the French Named Patient Programme: interest of monitoring blood concentration in clinical practice.

Shared by NobleBlocks on Aug 1, 2020 • 12:00 AM UTC

Authors:

Alain S

Feghoul L

Girault S

Abstract

Objectives To analyse mechanisms of letermovir breakthrough during compassionate primary and secondary prophylaxis.Methods Mechanisms of letermovir breakthrough during compassionate primary and secondary prophylaxis were analysed in four patients from the French Named Patient Programme by the French...

Discussions